Synthego Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 270
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $100M
Latest Deal Amount
  • Investors
  • 24

Synthego General Information

Description

Developer of a precision genome engineering platform designed to accelerate and optimize drug discovery research journey. The company's platform incorporates the use of informatics and machine learning and brings precision and automation to genome engineering, enabling genetic engineers and medical professionals to conduct rapid and cost-effective research with consistent results for every scientist.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • 3696 Haven Avenue
  • Suite A
  • Redwood City, CA 94063
  • United States
+1 (844) 000-0000

Synthego Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthego Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series D) 26-Aug-2020 $100M 00000 00000 Completed Generating Revenue
5. Later Stage VC (Series C) 23-Oct-2018 00000 00000 00000 Completed Generating Revenue
4. Early Stage VC (Series B) 04-Jan-2017 0000 000.00 00000 Completed Generating Revenue
3. Debt - General 05-Feb-2014 000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 05-Jul-2013 $8.29M $8.54M 000.00 Completed Generating Revenue
1. Angel (individual) 14-Aug-2012 $250K $250K Completed Startup
To view Synthego’s complete valuation and funding history, request access »

Synthego Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 17,369,511 $0.000100 $0.19 $2.41 $2.41 1x $2.41 20.39%
Series A 9,503,578 $0.000100 $0.07 $0.87 $0.87 1x $0.87 11.16%
To view Synthego’s complete cap table history, request access »

Synthego Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a precision genome engineering platform designed to accelerate and optimize drug discovery research journey
Biotechnology
Redwood City, CA
270 As of 2021
00000
0000 0000-00-00
00000000000 00000

0000000

. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
0000000000000
Berkeley, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cill
0000000000000
Santa Cruz, CA
0 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synthego Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Caribou Biosciences Venture Capital-Backed Berkeley, CA 00 00000 00000000000 00000
0000000000 Corporation Santa Cruz, CA 0 0000000000
000000 00000000000 Venture Capital-Backed Palo Alto, CA 00 00000 00000
00000000 Private Debt Financed Mountain View, CA 00 000000000 -
000000 00000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
You’re viewing 5 of 28 competitors. Get the full list »

Synthego Executive Team (14)

Name Title Board Seat Contact Info
Paul Dabrowski Co-Founder, Chief Executive Officer & Board Member
Michael Dabrowski Co-Founder, Advisor, President & Board Member
Forrest Baringer-Jones Chief Financial Officer
John Tan Chief Operating Officer
Jason Steiner Ph.D Chief Strategy Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Synthego Board Members (6)

Name Representing Role Since
Drew Oetting 8VC Board Member 000 0000
Francisco Gimenez Ph.D 8VC Board Observer 000 0000
Michael Dabrowski Synthego Co-Founder, Advisor, President & Board Member 000 0000
Nathaniel Brooks Horwitz RA Capital Management Board Observer 000 0000
Paul Dabrowski Synthego Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Synthego Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthego Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Andrew Garvin Angel (individual) Minority 000 0000 000000 0
Level One Fund Venture Capital Minority 000 0000 000000 0
Moshen Chan Angel (individual) Minority 000 0000 000000 0
RA Capital Management Hedge Fund Minority 000 0000 000000 0
Revelation Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 24 investors. Get the full list »